Felix Kratz

2017

In 2017, Felix Kratz earned a total compensation of $331.4K as Vice President – Drug Development at CytRx.

Compensation breakdown

Bonus$76,000
Option Awards$33,000
Salary$222,400
Total$331,400

Kratz received $222.4K in salary, accounting for 67% of the total pay in 2017.

Kratz also received $76K in bonus and $33K in option awards.

Rankings

In 2017, Felix Kratz's compensation ranked 13,090th out of 14,666 executives tracked by ExecPay. In other words, Kratz earned more than 10.7% of executives.

ClassificationRankingPercentile
All
13,090
out of 14,666
11th
Division
Manufacturing
5,158
out of 5,772
11th
Major group
Chemicals And Allied Products
1,873
out of 2,075
10th
Industry group
Drugs
1,561
out of 1,731
10th
Industry
Biological Products, Except Diagnostic Substances
284
out of 313
9th
Source: SEC filing on June 26, 2019.

Kratz's colleagues

We found two more compensation records of executives who worked with Felix Kratz at CytRx in 2017.

2017

Steven Kriegsman

CytRx

Chief Executive Officer

2017

John Caloz

CytRx

Chief Financial Officer

News

You may also like